First Cited
Last Cited

Articles citing This Document (Page 1 of 3)

Guidance for Transitioning Among AnticoagulantsAACN Advanced Critical Care2019
Thromboprophylaxis in Orthopedic Surgery2016
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE studyJournal of Thrombosis and Thrombolysis2021
Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control studyBritish Journal of Clinical Pharmacology2020
Drug-Drug Interactions with Direct Oral AnticoagulantsClinical Pharmacokinetics2020
Cardiovascular Risk Management and Hepatitis C: Combining DrugsClinical Pharmacokinetics2019
A Generic Model for Quantitative Prediction of Interactions Mediated by Efflux Transporters and Cytochromes: Application to P-Glycoprotein and Cytochrome 3A4Clinical Pharmacokinetics2019
Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulantsJournal of Thrombosis and Haemostasis2019
How Does "Regulatory Practice" Create Discrepancies in Drug Label Information Between Asian and Western Countries? Different Label Information for Direct Oral Anticoagulants Approved in the United States, Europe, Korea, and JapanTherapeutic Innovation and Regulatory Science2019
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel ReportChest2018
Oral Anticoagulation in Patients With Liver DiseaseJournal of the American College of Cardiology2018
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillationThrombosis Journal2018
Management of Dabigatran-associated bleeding in two elderly patients with acute renal failureAnnals of Hematology2018
Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patientsJournal of Thrombosis and Thrombolysis2018
Hepatotoxicity of New Oral AnticoagulantsRational Pharmacotherapy in Cardiology2018
Use of oral anticoagulants in German nursing home residents: drug use patterns and predictors for treatment choiceBritish Journal of Clinical Pharmacology2018
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for cliniciansJournal of Thrombosis and Haemostasis2018
Direct-acting oral anticoagulant drug level monitoring in clinical patient managementJournal of Thrombosis and Thrombolysis2018
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or VomitingOncologist2018
Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxabanCurrent Medical Research and Opinion2018
Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?Research and Practice in Thrombosis and Haemostasis2018
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver InjuryJournal of the American College of Cardiology2018
Haematological factors in the management of adult epistaxis: systematic reviewJournal of Laryngology and Otology2017
Direct oral anticoagulant considerations in solid organ transplantation: A reviewClinical Transplantation2017
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysisBritish Journal of Clinical Pharmacology2017
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACsEuropean Journal of Clinical Pharmacology2017
Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health recordsEuropean Journal of Clinical Pharmacology2017
Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current viewsHemodialysis International2017
Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA)European Heart Journal - Cardiovascular Pharmacotherapy2017
Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillationExpert Opinion on Pharmacotherapy2017
Medication errors involving anticoagulants: Data from the Danish patient safety databasePharmacology Research and Perspectives2017
Perioperative management of patients on direct oral anticoagulantsThrombosis Journal2017
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycinJournal of Thrombosis and Haemostasis2017
Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatmentInternational Journal of Hematology2017
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillationJournal of Thrombosis and Thrombolysis2017
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulantsCritical Care2017
Novel oral anticoagulants and the 73rd anniversary of historical warfarinJournal of the Saudi Heart Association2016
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndromeRheumatology2016
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral AnticoagulantsCardiovascular Drugs and Therapy2016
Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient settingThrombosis Journal2016
Drug Treatment of Venous Thromboembolism in the ElderlyDrugs and Aging2016
The Effect of Cardiopulmonary Bypass on Dabigatran LevelsJournal of Cardiothoracic and Vascular Anesthesia2016
Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgeryInternational Urogynecology Journal2016
Glomerular filtration rate assessed by using creatinine and cystatin in patients treated with dabigatranRivista Italiana Della Medicina Di Laboratorio2016
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICEThrombosis and Haemostasis2016
The use of novel oral anticoagulants in cancer patients with venous thromboembolismSeminars in Oncology2016
Drug-drug interactions of non-vitamin K oral anticoagulantsExpert Opinion on Drug Metabolism and Toxicology2016
Use of direct oral anticoagulants with regional anesthesia in orthopedic patientsJournal of Clinical Anesthesia2016
Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationEuropean Heart Journal Supplements2016
Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillationEuropean Heart Journal Supplements2016